
Article 1 
The watch list of substances ... monitoring referred to in Article 8b of Directive 2008/105/EC is set out in the Annex to this Decision.
Article 2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Done at Brussels, 5 June 2018.
For the Commission
Karmenu VELLA
Member of the Commission
ANNEX

Name of substance/group of substances CAS number EU number Indicative analytical method Maximum acceptable method detection limit (ng/l)
17-Alpha-ethinylestradiol (EE2) 57-63-6 200-342-2 Large-volume SPE - LC-MS-MS 0,035
17-Beta-estradiol (E2), Estrone (E1) 50-28-2,53-16-7 200-023-8 SPE - LC-MS-MS 0,4
Macrolide antibiotics   SPE - LC-MS-MS 19
Methiocarb 2032-65-7 217-991-2 SPE - LC-MS-MSor GC-MS 2
Neonicotinoids   SPE - LC-MS-MS 8,3
Metaflumizone 139968-49-3 604-167-6 LLE - LC-MS-MS or SPE – LC-MS-MS 65
Amoxicillin 26787-78-0 248-003-8 SPE - LC-MS-MS 78
Ciprofloxacin 85721-33-1 617-751-0 SPE - LC-MS-MS 89





